American Portfolios Advisors’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

American Portfolios Advisors’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-20	Closed	-$12	–	2700
2018 Q4	$12	Hold	20	–	–	﹤0.01%	2392
2018 Q3	$26	Hold	20	–	–	﹤0.01%	2400
2018 Q2	$27	Hold	20	–	–	﹤0.01%	2369
2018 Q1	$29	Buy	+20	New	+$42	﹤0.01%	2296

American Portfolios Advisors's AST Position: Q1 2019 in Review

American Portfolios Advisors sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 20 shares — an estimated $12 sold.

American Portfolios Advisors first reported a position in AST in Q1 2018 and held it in 4 quarters. The position peaked at $29 in Q1 2018. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

American Portfolios Advisors reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
American Portfolios Advisors sold 20 Asterias Biotherapeutics Inc. Series A shares in Q1 2019, an estimated $12.
American Portfolios Advisors first reported a position in Asterias Biotherapeutics Inc. Series A in Q1 2018 and held it in 4 quarters.
American Portfolios Advisors's Asterias Biotherapeutics Inc. Series A position peaked at $29 in Q1 2018.
0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on American Portfolios Advisors's 13F filing for Q1 2019, filed 24 Mar 2023.